Dirk Haussecker Profile Banner
Dirk Haussecker Profile
Dirk Haussecker

@RNAiAnalyst

Followers
18,529
Following
505
Media
1,433
Statuses
37,859

Biotech enthusiast. There are no alternative truths. Let science and reason lead the way. Defend democracy and freedom of life. Not investment advice

Germany
Joined November 2011
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@RNAiAnalyst
Dirk Haussecker
2 years
FDA to Novavax: give me data from 5 clinical trials, incl 2 phase 3s, effectivemess of #boosters in current BA.5 wave+ we'll get back to you in couple of months. FDA to Moderna and Phizer: rodent data? That's so kind of you, but we wanted to authorize you regardless of data.
18
50
199
@RNAiAnalyst
Dirk Haussecker
4 years
$MRNA market+politicians say, let's unleash this vaccine w/ this type of safety profile onto hundreds of millions of people: mind...boggles
Tweet media one
41
43
147
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX Korean media: it is a good vaccine, v efficacious + less side effects than mRNA. Western media: Novavax is a second tier vaccine, only suitable for mRNA hesitant covidiots. --> Korean media are closer to scientific data, while Western mainstream media parrots politics.
5
18
137
@RNAiAnalyst
Dirk Haussecker
4 years
#covidvaccine rankings. Efficacy (against wild-type): $NVAX 96% $BNTX $PFE 95% $MRNA 94% Safety: $NVAX...................................(a marathon distance) $BNTX.. $MRNA
29
36
137
@RNAiAnalyst
Dirk Haussecker
4 years
Strong presumption that $MRNA #covidvaccine infringes on $ABUS patent (blog): $BNTX $PFE
17
43
125
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX on day 2, Nuvoxavid has become number 1 primary covid vaccine in Korea 🇰🇷: $BNTX $MRNA
Tweet media one
8
23
114
@RNAiAnalyst
Dirk Haussecker
2 years
Yesterday, I was fortunate to visit $PRQR headquarters. Here are my impressions. A bit wordy, but worth your time if this is more than a short-term trade for you (blog): $WVE #RNAEditing
12
14
112
@RNAiAnalyst
Dirk Haussecker
11 months
$XBI congrats biotech investors: you are true survivors and will likely have caught the bottom. Large fortunes await many of you.
10
6
111
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX Fauci firmly on our side now. A week after criticizing mRNAs for short-lived protection against #covid19 , #Fauci /NIH now going head-to-head against Moderna in Epstein-Barr. And guess what? NIH adopts @Novavax MatrixM adjuvant!!!
8
14
107
@RNAiAnalyst
Dirk Haussecker
4 years
$AFMD not really surprised by the muted reaction. If u are, however, 1 of the few that don't mind having long-term position in portfolio, this could be 1. The +20% today pales in comparison to the importance of today's data.
12
11
98
@RNAiAnalyst
Dirk Haussecker
4 years
$NVAX I didn't go through all this pain + frustration to sell for $170. Thank you, @novavax .
15
8
99
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX photos of Nuvaxovid being sent out for delivery; tears of joy to the eyes of #Novastans :
Tweet media one
12
21
98
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax has shipped today vaccine to EU!
4
9
95
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX I expect US authorization within a week. FDA can't ignore positive panel comments today.
14
11
95
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX once I have lost all my livelihood (not far from it actually), I will use the time to dig into the unholy Reuters-Phizer-FDA triade. It's sickening e.g. to see Reuters come out with myocarditis hit piece the minute the Briefing Docs became available. cc: @Reuters_Health
16
3
95
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX time to take a celebratory lap. #VRBPAC
6
1
93
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX now has market access to probably 40% of world population (a cool 1 billion added yesterday alone), yet investors obsess abt US approval (3% of world pop). In general, covid vaccine stocks go up/down based on how covid risk is perceived in the US. 🙄 $BNTX $MRNA
20
13
89
@RNAiAnalyst
Dirk Haussecker
3 years
Dear @US_FDA ...maybe approve #Novavax now to save a few lives before the impending BA2 wave swallows many of the unvaccinated...and more? Just a little suggestion.
11
13
90
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX no #myocarditis in this 2000+ adolescent trial; No #myocarditis imbalance in ~50000 trial participants btw nvx2373 and placebo. $BNTX $MRNA
4
10
90
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX just demonstrated that Novavax boosts best upon Novavax which broadens immune response to cover (future) variants. No need to take chances on fancy #bivalents . If you just compared #booster data of Novavax vs #Phizer and $MRNA, Novavax would come out on top.
7
20
89
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax there is no scientific justification for not approving it in US. Surprised there is no general biotwitter outrage at apparent corruption in US covidvaccine policy. I guess, corruption is widely accepted a way of life, so get on with it. #Phizer $mrna
10
4
86
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX (extraordinary) WHO meeting...the real action about to start in 4 minutes:
Tweet media one
9
19
89
@RNAiAnalyst
Dirk Haussecker
10 months
$cytk what the heck was this? CEO just said on call that '3rd parties' have already called that dataset 'pristine'. He could not be any clearer that M&A talks ongoing.
3
7
88
@RNAiAnalyst
Dirk Haussecker
3 years
$XBI sell-off starting to take my breath away. As if biotech companies had no future value whatsoever.
10
2
85
@RNAiAnalyst
Dirk Haussecker
4 years
$MRNA of course, the most disappointing data (along w/ iffy safety profile) was crammed into end of results section: poor T cell responses, esp CD8. $BNTX $NVAX $INO
Tweet media one
9
21
85
@RNAiAnalyst
Dirk Haussecker
5 months
$ARWR folks, it's not even a competition at this point. Based on trig lowering alone, nobody in good conscience will prescribe $IONS olezarsen over $ARWR plozasiran. Glad we settled the debate over which one is the more potent trig-lowering drug.
Tweet media one
5
15
85
@RNAiAnalyst
Dirk Haussecker
2 years
2 reasons to get #boosted with $nvax: 1) if it's your 1st Novavax shot, tolerability should be excellent; 2) if u believe #covid19 will be mutating + with us for awhile, the earlier u switch to NVAX, the sooner pan-variant protection (3/4 shots of NVAX). I've made the switch.
11
14
81
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax Europe is suddenly panicking over #omicron ....lockdowns, harsh quarantine +travel rules. EMA approval tomorrow could not come at a better time for #nuvaxovid .
8
7
77
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX Rheinland Palatinate (pop 4M) opened Nuvaxovid registrations today (1st German state to do so). By 2pm, 5000 have already registered per the state minister. Will gather speed IMO.
7
11
77
@RNAiAnalyst
Dirk Haussecker
3 years
Rare moment of pride.
@BNOFeed
BNO News
3 years
NEW: Germany rejects proposal to waive patent protection for COVID-19 vaccines, says IP is a "source of innovation and must remain so in the future" - DW
29
122
406
2
2
79
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX 2 phase 3 trials; India, Korea, Japan bridging studies...at least 5 different materials used all yielding consisting safety + immunogenicity... US FDA questioning how old studies relate to current (improved) manufacturing is purely academic exercise to SLOW-Walk approval.
14
9
81
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax let's face it: nuvaxovid will be the people's vaccine. EU accelerating delivery request a result of that.
2
7
82
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX very important after first 2 months of vaccine roll-out: detailed surveillance in Korea 🇰🇷 and Australia 🇦🇺 support that Nuvaxovid/Covovax substantially better tolerated + safer than mRNAs + adenos.
1
11
79
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax Yessszzzz! 1st news item of 7pm Deutschlanfunk news ('German BBC')... Vaccine mandate for medical sector very likely to be delayed to give people chance to get #Novavax !
3
7
78
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX a scandal that the US regulatory agencies won't provide companies like Novavax certainty on openness of EUA pathway.
12
10
76
@RNAiAnalyst
Dirk Haussecker
4 years
My main long positions: $afmd (NK cell; long-term) $ions (antisense; long-term) $sln (RNAi; Lpa story) $NVAX (pandemic trade) $BNTX (pandemic trade) 2 shorts $MRNA (into AdCom/Briefing docs -->poor safety) $TSLA (increased competition with superior manufacturing)
13
8
77
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX Disgusted that apart from initial OWS funding award, the world's most promising #covidvaccine has received so little public-private support. No bags, filters, nor any kind of regulatory short-cuts, only impediments. Should have been approved 6 months ago.
10
10
77
@RNAiAnalyst
Dirk Haussecker
4 years
#Sinovac 63%, not 78% effective Inactivated #CovidVaccine data gets dodgier still as now 'they' apparently cannot even do simple math: According to numbers (~220 infected, 60 vaccine, 160 pbo) it's 63% effective, not 78%.
6
32
76
@RNAiAnalyst
Dirk Haussecker
3 months
#IRA Potentially HUGE development for oligonucleotide therapeutics: per Novartis CEO, BIPARTISAN bill making good progress on giving gene-targeted therapeutics 13 instead of (small molecule) 9 year protection. ALSO: drug with multiple, not just 1 orphan indication to be exempt
8
9
77
@RNAiAnalyst
Dirk Haussecker
2 years
#VRBPAC yet another panel member urges FDA to approve #Novavax since they had the most impressive data today!!!!
3
9
76
@RNAiAnalyst
Dirk Haussecker
7 days
$PRQR thanks all that invested along with me (and also those that did not)...and yet nobody dunked on me when stock was languishing. Today was a big de-risking step; from now on flawless clinical execution.
10
1
80
@RNAiAnalyst
Dirk Haussecker
4 years
$AFMD patient 3 (a CR) was supposed to go to hospice, then received AFM13 loaded onto cord blood-derived NK cells...complete response, now about to receive allogeneic transplant.
5
9
73
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax it's comforting that no speculations around safety have cropped up since introduction of #covovax into Indonesia's vaccination campaign. If #Novavax can maintain its safety + tolerability advantage over mRNAs, it will emerge as the premier covidvaccine brand in due course.
2
6
75
@RNAiAnalyst
Dirk Haussecker
4 years
$NVAX apples-to-apples Novavax has better efficacy than $MRNA and $BNTX $PFE: 95.6% against wild-type strain
Tweet media one
5
20
75
@RNAiAnalyst
Dirk Haussecker
3 years
$afmd i've hit my 1% ownership goal. If there will be pandemic of cancer + stock up to $mrna valuations, I'll be a billionaire ahead of schedule :)
9
4
74
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX next week is going to be BIG: Japan decision and covid19-flu combo study data at World Vaccine Congress:
4
11
72
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX public hearing session shaming FDA for withholding vaccine available in most other countries, dishing their citizens up only mRNA. 'Only FDA knows why'. #VRBPAC
5
7
74
@RNAiAnalyst
Dirk Haussecker
3 years
@novavax ...it's time for you to stand up for yourself and correct the falsehoods in the @reuters article... ...and send a warning to Reuters + people behind them that they will be investigated.
13
11
75
@RNAiAnalyst
Dirk Haussecker
2 years
$arwr OMG..a day for the oligoRx history books: potent (and safe!) target gene knockdown in the lung. Drops phone....
4
15
74
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX as a long-time biotech investor, I knew that the FDA was highly conflicted...but #Novavax is taking it to a new level.
8
5
74
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX from tomorrow on, Nuvaxovid will be available in Nova Scotia 🇨🇦 as dose 1, 2, OR 3/BOOSTER, including heterologous. First agency in the world to allow such broad use (only restriction is age >18 years).
Tweet media one
3
9
72
@RNAiAnalyst
Dirk Haussecker
4 years
Fell off chair when I revisited cause of the JNJ (adeno-based) #covidvaccine trial pause in Oct '20: CEREBRAL SINUS VEIN THROMBOSIS (in young person). --> almost certain that #AstraZeneca 's troubles extend across adenoviral franchise @matthewherper
Tweet media one
5
17
74
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax best-in-class covid and malaria vaccines, first flu-covid vaccine data, 2022-3 APA+ other high-margin funding close to $10B.... .....market cap $3.5B. A joke.
7
6
71
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX to be used as booster in Ireland (EU country): 'Minister Donnelly said: “I welcome this update to our booster vaccination programme'
7
10
71
@RNAiAnalyst
Dirk Haussecker
2 years
$nvax booster approval in Australia, incl heterologous This...is...so...incredibly...important to see such approvals following primary-only approvals. Future secured.
2
4
72
@RNAiAnalyst
Dirk Haussecker
3 years
Here's hoping the Bill & Melinda Gates Foundation will continue to live on in its current incarnation. Arguably the most impactful org when it comes to addressing health issues in poor countries.
7
6
71
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX very bullish for next week. Once market realizes that vaccine not only got approvals, but Co confirms that it's getting cleared+shipped, stock should bounce strongly. Plus likely approval news from South Korea + Australia. jmho
11
13
71
@RNAiAnalyst
Dirk Haussecker
4 years
@EricTopol That's not correct. CVST was seen in JNJ phase 3 trial and was cause of trial halt last Oct:
Tweet media one
1
6
70
@RNAiAnalyst
Dirk Haussecker
3 years
$nvax some nuggets from Q&A: - COGS of $3-5/dose; since many doses already expensed as R&D, there will be 0 COGS doses initially -SK sitting on 100M doses, ready to go when approved as manufacturing site - US order not included in 4-5B 2022 rev guidance, represents upside
5
9
69
@RNAiAnalyst
Dirk Haussecker
2 years
$nvax I will be livid if the FDA ends up giving Novavax a narrower label than the mRNAs because of myocarditis. Never underestimate corruption at agency.
12
3
71
@RNAiAnalyst
Dirk Haussecker
2 years
Variant #VRBPAC panel member Adam Berger says that strain-adaptation may only be needed for mRNA platform; he's impressed by one-size-fits-all-strains Novavax! $NVAX $BNTX $MRNA
3
11
71
@RNAiAnalyst
Dirk Haussecker
1 month
$ARWR making 5-year lows after best-in-class hypertrig data which open potential to label well beyond small FCS population. #confused
15
0
71
@RNAiAnalyst
Dirk Haussecker
4 years
$NVAX we may be in the middle of perfect storm: 1) adenoviral #covidvaccines drop out 2) prices going up 3) US phase 3 results imminent 4) imminent regulatory approvals followed by new orders
4
14
71
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX now overtaking $MRNA for 1st, 2nd, 3rd, and 4th shot in Korea 💪. 15-20% market share. #Phizer still dominating, late-coming homegrown competition from SK Bio without traction.
Tweet media one
8
14
70
@RNAiAnalyst
Dirk Haussecker
3 years
SOOO excited. #Novavax is coming to my area. Special vaccination day next week Feb24 if you are in the #Rastatt #BadenBaden area! $NVAX
Tweet media one
6
6
68
@RNAiAnalyst
Dirk Haussecker
5 months
$ARWR big congrats to company. Not 1, but 2 @nejm publications for 2 different drugs. Personally, starting to like Zodasiran more and more.
Tweet media one
Tweet media two
1
8
70
@RNAiAnalyst
Dirk Haussecker
4 years
Moderna would like to tell you a #covidvaccine joke, but it's not theirs. $abus
5
8
67
@RNAiAnalyst
Dirk Haussecker
3 years
Expert says 200M doses of $NVAX #covovax ready to be rolled out in 'Big Way'! Expert says he's in close contact w/ Serum. Co says >90% effective against #omicron !! Says AZ homologous booster useless, expects #covovax to be used as booster, too.
@ndtv
NDTV
3 years
#COVID19 | "The new vaccine #covovax from Serum Institute is very effective...currently, most patients we're seeing are asymptomatic": Dr @PurvezGrant , Member, Covid Task Force, #Karnataka , on rollout of the "precautionary dose" of the #CovidVaccine today. #BoosterJab
14
32
127
4
17
64
@RNAiAnalyst
Dirk Haussecker
3 years
Just talked to person co-ordinating it, says phone ringing off the hook. Said #Novavax seems to have hit a nerve. Nobody wants #Moderna or #Biontech any more. $NVAX
@RNAiAnalyst
Dirk Haussecker
3 years
SOOO excited. #Novavax is coming to my area. Special vaccination day next week Feb24 if you are in the #Rastatt #BadenBaden area! $NVAX
Tweet media one
6
6
68
7
17
68
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX totally confused abt market reaction to what seem STELLAR data: - only a bit more than 4x drop in neutralization #omicron vs wild-type for 2-dose - 3rd dose peak responses greatly exceed 2-dose, incl omicron/delta; SAEs comparable to placebo -great adolescent response
11
12
66
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX while Moderna and Biontech/Pfizer talk about 20-40x drop in neutralization prototype vs #omicron , Novavax maybe 5x... ....and 3rd shot for omicron almost as good as 2 shots for prototype (Moderna sees drop)!
Tweet media one
5
14
65
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX Stan is right to call out corruption of US regulators. Nothing to lose. They've been laughing their heads off at how quiet Co had been taking this. + funny analyst predicting $5B revenues on 2B doses. So @novavax will just give it away?
Tweet media one
14
8
67
@RNAiAnalyst
Dirk Haussecker
2 months
$arwr Plozasiran (RNAi) reduced triglycerides -79% in both genetic and clinically defined FCS. Huge -95% target ApoC3 knockdown. $ions olezarsen: -45% TG at high dose that had safety issues. Because plozasiran was stat sig for TG reductions, they can claim #pancreatitis
@ArrowheadPharma
ArrowheadPharma
2 months
Results from our Phase 3 study of our #RNAi therapy for adults with familial chylomicronemia syndrome were presented at @escardio #ESCCongress 2024 and simultaneously published in @NEJM . Learn more here:
Tweet media one
9
5
55
4
7
68
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX Take-homes: 👉FDA agrees w/ need for mRNA alternative 👉sticking point has been manufacturing quality (not efficacy, safety) 👉Dubovsky (Novavax) says issues solved 👉VRBPAC meeting before approval 👉FDA needs a new travel agent
@WSJhealth
WSJ Health
3 years
Novavax says it has resolved the manufacturing problems that delayed U.S. authorization of its Covid-19 vaccine. Health regulators have begun their review.
12
28
98
7
8
66
@RNAiAnalyst
Dirk Haussecker
3 years
Now Reuters 'updates' their article to admit to their omission of the 28M shipped in addition to the 10M Indonesian doses. Too bad, 90% of those that read original article will never see the 'update'. How the game is played. $NVAX
11
13
66
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX Europe is in the midst of the biggest Covid wave yet... ....but regulators taking their sweet time to approve vaccine that vaccine hesitants are clamoring for. No rush, no rush...
4
4
65
@RNAiAnalyst
Dirk Haussecker
11 months
$arwr a mgmt that has been able to solve delivery for the #lung (90%+ kd) years ahead of competition has my full confidence that they are in control of capital needs. Market reaction last week so non-sensical...as if there was no demand for targeting lung, plus all the other
5
10
67
@RNAiAnalyst
Dirk Haussecker
2 years
$NVAX Fauci bombshell: Criticizes short durability of mRNA vaccines. 'Got to do better' --> new platforms, immunogens, MAYBE ADJUVANTS! Here's the long version where he indicates Novavax to come online soon (~19min):
4
10
66
@RNAiAnalyst
Dirk Haussecker
1 year
$ARWR whoaaaa.... CEO thinks they are close to SYSTEMIC admin for #CNS targets. whoaaa. to be discussed at investor day.
5
6
65
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX setting the stage for robust fall uptake of its #covidvaccine : 2-shot approval adults --> 2-shot approval adolescents --> booster approval --> demonstration that Novavax protein booster superior to mRNAs against emerging variants
5
7
66
@RNAiAnalyst
Dirk Haussecker
2 years
When even CDC/FDA admit that there is a 'possible' #stroke risk from #Phizer mRNA vaccine...then save to assume it's a definitive risk. So stroke and heart attacks for elderly, sudden death in young males... maybe give $NVAX vaccine a chance?
14
14
65
@RNAiAnalyst
Dirk Haussecker
4 years
LOL. $NVAX released much better data last night. Crickets from Fauci and Gottlieb. Now the expected game-changer rhetoric. Got it, but no thanks.
10
14
64
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX imagine how this only truly global protein-based covid vaccine player might explode to upside... ...if our dear health authorities actually look at safety data, get cold feet + recommend #protein over #mRNA in 'endemic setting'.
4
7
61
@RNAiAnalyst
Dirk Haussecker
7 months
Congrats, @ArrowheadPharma , I hereby anoint you the clear ApoCIII winner. $ARWR $IONS
4
5
66
@RNAiAnalyst
Dirk Haussecker
2 years
Anecdotal from family: more are making switch to #Novavax as they have been witnessing sometimes severe side effects from mRNA. Not stuff from covidiots on the net. So far, heterologous boosting without side effect, except for euphoria in my case. $nvax
6
7
62
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX starting tomorrow, it will be 3 geographies rolling out #Nuvaxovid : Korea 🇰🇷, Australia 🇦🇺, and the EU 🇪🇺.
9
10
62
@RNAiAnalyst
Dirk Haussecker
4 months
$ARWR with INHBE preclinical results. Weight loss while lean mass preserved. $WVE $ALNY
2
7
65
@RNAiAnalyst
Dirk Haussecker
5 years
$ARWR I'm in awe: crazily efficient mean max TRIG reduction of -95% in severe hypertrig patients following single dose of mere 50mg: $AKCA doesn't hold a candle.
8
9
65
@RNAiAnalyst
Dirk Haussecker
3 years
More people registered for (primary vaccinations with) #Novavax this week alone in German state of Rhineland-Palatinate than primary vaccinations in last 3 months combined! $NVAX
1
6
62
@RNAiAnalyst
Dirk Haussecker
3 years
$NVAX great, #Novastans (🤣), we are already being called a 'cult'. Wouldnt mind becoming embroiled in the next $GME-type short squeeze:
8
6
63